← Open Payments lookup

CAROL COVARRUBIAS: Open Payments

NPI 1972118404 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$550 in 18 payments from 9 companies in 2025. Trend: 2023 $143 · 2024 $139 · 2025 $550

Food & beverage: $550
CompanyPaymentsAmount
Janssen Biotech, Inc.1$121
E.R. Squibb & Sons, L.L.C.4$107
ARRAY BIOPHARMA INC4$89
Daiichi Sankyo Inc.3$88
Eisai Inc.2$41
JAZZ PHARMACEUTICALS INC.1$29
AstraZeneca Pharmaceuticals LP1$29
Gilead Sciences, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$23

Products named: RYBREVANT, OPDIVO, BRAFTOVI, Enhertu, Lenvima, DATROWAY, ZEPZELCA, Trodelvy.

Industry payments across FL — which companies pay providers there.